Skip to Main Content

Paper Details

Co-evolution of tumor and immune cells during progression of multiple myeloma.
Nat Commun
65
2021
cell_line 0 0.6398637890815735 CUI-less NULL NULL NULL NULL NULL NULL NULL pubmed22n1083.json
401319033 33963182 982 1025 B cell-featured plasma cell subpopulations, AP-1, AP-1 complex, B cells, FOS, IL1B, IL6, JUN, MM, Multiple myeloma, Patients, cell RNA, downstream targets, immune cells, multiple myeloma, patient, patients, plasma cell, plasma cell subpopulations, plasma cells, precancer, single cell RNA, tumor, tumor and immune cells
Author NameAffiliation
Ruiyang LiuWashington University in St. Louis
Ruiyang LiuMcDonnell Genome Institute, Washington University in St. Louis
Qingsong GaoWashington University in St. Louis
Qingsong GaoMcDonnell Genome Institute, Washington University in St. Louis
Steven M FoltzWashington University in St. Louis
Steven M FoltzMcDonnell Genome Institute, Washington University in St. Louis
Steven M FoltzWashington University in St. Louis
Steven M FoltzMcDonnell Genome Institute, Washington University in St. Louis
Lijun YaoWashington University in St. Louis
Lijun YaoMcDonnell Genome Institute, Washington University in St. Louis
Song CaoWashington University in St. Louis
Song CaoMcDonnell Genome Institute, Washington University in St. Louis
Song CaoWashington University in St. Louis
Song CaoMcDonnell Genome Institute, Washington University in St. Louis
Michael C WendlMcDonnell Genome Institute, Washington University in St. Louis
Michael C WendlWashington University in St. Louis
Michael C WendlWashington University in St. Louis
Michael C WendlMcDonnell Genome Institute, Washington University in St. Louis
Michael C WendlWashington University in St. Louis
Michael C WendlWashington University in St. Louis
Sunantha SethuramanWashington University in St. Louis
Sunantha SethuramanMcDonnell Genome Institute, Washington University in St. Louis
Christopher J YoonWashington University in St. Louis
Christopher J YoonMcDonnell Genome Institute, Washington University in St. Louis
Matthew A WyczalkowskiWashington University in St. Louis
Matthew A WyczalkowskiMcDonnell Genome Institute, Washington University in St. Louis
Matthew A WyczalkowskiWashington University in St. Louis
Matthew A WyczalkowskiMcDonnell Genome Institute, Washington University in St. Louis
Joshua F McMichaelWashington University in St. Louis
Joshua F McMichaelMcDonnell Genome Institute, Washington University in St. Louis
Joshua F McMichaelWashington University in St. Louis
Joshua F McMichaelMcDonnell Genome Institute, Washington University in St. Louis
Robert S FultonMcDonnell Genome Institute, Washington University in St. Louis
Robert S FultonMcDonnell Genome Institute, Washington University in St. Louis
Catrina FronickMcDonnell Genome Institute, Washington University in St. Louis
Timothy J LeyWashington University in St. Louis
Reyka G JayasingheWashington University in St. Louis
Reyka G JayasingheMcDonnell Genome Institute, Washington University in St. Louis
Reyka G JayasingheWashington University in St. Louis
Reyka G JayasingheMcDonnell Genome Institute, Washington University in St. Louis
Stephen T OhWashington University in St. Louis
Stephen T OhCenter for Human Immunology and Immunotherapy Programs, Washington University in St. Louis
John F DiPersioWashington University in St. Louis
John F DiPersioSiteman Cancer Center, Washington University in St. Louis
Ravi VijWashington University in St. Louis
Ravi VijSiteman Cancer Center, Washington University in St. Louis
Li DingWashington University in St. Louis
Li DingMcDonnell Genome Institute, Washington University in St. Louis
Li DingWashington University in St. Louis
Li DingSiteman Cancer Center, Washington University in St. Louis
  • 1 - 50

Datasets